Familial Success in Allergen Desensitization.

Marija J RowaneRyan ShilianDevi K JhaveriHaig H TcheurekdjianTheordore H SherRobert Hostoffer

Published in: Allergy & rhinology (Providence, R.I.) (2019)

In a subpopulation of SCIT patients, there appears to be a familial success rate with this allergen desensitization treatment. This is the first reported pharmocogenetic evidence of assessing hereditary influence on effective AR therapy. Understanding pharmacogenetic associations involved with SCIT may improve allergists' recommendations for this treatment option.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
clinical practice
bone marrow
mesenchymal stem cells
allergic rhinitis